ProKidney Corp (NASDAQ:PROK) shares, rose in value on Thursday, July 10, with the stock price up by 19.35% to the previous day’s close as strong demand from buyers drove the stock to $5.18.
Actively observing the price movement in the last trading, the stock closed the session at $4.34, falling within a range of $4.5 and $5.95. The value of beta (5-year monthly) was 1.456. Referring to stock’s 52-week performance, its high was $7.13, and the low was $0.46. On the whole, PROK has fluctuated by 428.57% over the past month.
With the market capitalization of ProKidney Corp currently standing at about $1.52 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-12.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PROK’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 25% Sell while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of PROK currently trading nearly 306.06% and 423.96% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 92.33, while the 7-day volatility ratio is showing 103.70% which for the 30-day chart, stands at 38.13%. Furthermore, ProKidney Corp (PROK)’s beta value is 1.41.
A comparison of ProKidney Corp (PROK) with its peers suggests the former has fared considerably weaker in the market. PROK showed an intraday change of 19.35% in last session, and over the past year, it grew by 206.51%%.
Data on historical trading for ProKidney Corp (NASDAQ:PROK) indicates that the trading volumes over the past 10 days have averaged 64.58 and over the past 3 months, they’ve averaged 10.19 million. According to company’s latest data on outstanding shares, there are 129.54 million shares outstanding.
Nearly 27.29% of ProKidney Corp’s shares belong to company insiders and institutional investors own 41.58% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 16.8 million shares as on 2025-06-13, resulting in a short ratio of 32.47. According to the data, the short interest in ProKidney Corp (PROK) stood at 1849.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 15.94 million. The stock has risen by 134.39% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PROK stock heading into the next quarter.
